| Literature DB >> 27943302 |
Rachel A North1, Andrew J A Watson2, F Grant Pearce1, Andrew C Muscroft-Taylor3, Rosmarie Friemann4,5,6, Antony J Fairbanks1,2, Renwick C J Dobson1,7.
Abstract
N-Acetylneuraminate lyase is the first committed enzyme in the degradation of sialic acid by bacterial pathogens. In this study, we analyzed the kinetic parameters of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus (MRSA). We determined that the enzyme has a relatively high KM of 3.2 mm, suggesting that flux through the catabolic pathway is likely to be controlled by this enzyme. Our data indicate that sialic acid alditol, a known inhibitor of N-acetylneuraminate lyase enzymes, is a stronger inhibitor of MRSA N-acetylneuraminate lyase than of Clostridium perfringens N-acetylneuraminate lyase. Our analysis of the crystal structure of ligand-free and 2R-sialic acid alditol-bound MRSA N-acetylneuraminate lyase suggests that subtle dynamic differences in solution and/or altered binding interactions within the active site may account for species-specific inhibition.Entities:
Keywords: N-acetylneuraminate lyase; antibiotic resistance; drug discovery; inhibitor; methicillin-resistant Staphylococcus aureus; sialic acid degradation; structure
Mesh:
Substances:
Year: 2016 PMID: 27943302 DOI: 10.1002/1873-3468.12462
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124